1. 3067 Randomized phase II trial of standard daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer: North Japan Lung Cancer Group Trial NJLCG1102. (September 2015) Authors: Saito, R.; Suzuki, A.; Maemondo, M.; Sugawara, S.; Nakagawa, T.; Taima, K.; Inoue, A.; Matsuno, K.; Usui, K.; Yokoi, T.; Kanbe, M.; Nukiwa, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗